Gastroesophageal reflux disease
Tracked across 1 events · 32 articles · First seen Aug 20, 2026 · Last active Sep 08, 2026
Live sentiment trends, attention charts, and prominence tracking available on the
Ergen Dashboard
Regulatory
Implantica AG, a Liechtenstein-based medtech company, received Premarket Approval (PMA) from the U.S. United States — Food and Drug Administration (FDA) for its RefluxStop device, an implantable treatment for gastroesophageal reflux disease (GERD). The approval,…
Impact: GERD is the medical condition treated by RefluxStop, with a large global patient population, underpinning the market opportunity.
Aug 20, 2026 · 32 articles
ERGEN INTELLIGENCE
Track Gastroesophageal reflux disease live
Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.
Open Dashboard